phenoxybenzamine has been researched along with allopurinol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Armstrong, DM; Fernando, AR; Griffiths, JR; Hendry, WF; O'Donoghue, EP; Perrett, D; Ward, JP; Wickham, JE | 1 |
| Chatterjee, SN | 1 |
| Kokas, P; Kupcsulik, P | 1 |
| Ikai, I; Kamiyama, Y; Morimoto, T; Nakase, Y; Ozaki, N; Ozawa, K; Shimahara, Y; Tokunage, Y; Wakashiro, S; Yamaoka, Y | 1 |
| Moberg, AW; Najarian, JS; Toledo-Pereyra, LH | 1 |
| Campos, RA; Moberg, AW; Mozes, MF; Najarian, JS; Toledo-Pereyra, LH | 1 |
2 review(s) available for phenoxybenzamine and allopurinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacologic agents of potential value in protecting kidneys from ischemic damage.
Topics: Adrenal Cortex Hormones; Allopurinol; Animals; Chlorpromazine; Dogs; Glutathione; Humans; Ischemia; Kidney; Kidney Transplantation; Magnesium Sulfate; Malonates; Organ Preservation; Oxamic Acid; Phenoxybenzamine; Rats; Tissue Preservation | 1977 |
11 other study(ies) available for phenoxybenzamine and allopurinol
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Enhanced preservation of the ischaemic kidney with inosine.
Topics: Adenosine; Adenosine Triphosphate; Allopurinol; Animals; Creatinine; Cyclic AMP; Inosine; Ischemia; Kidney; Kidney Transplantation; Organ Preservation; Perfusion; Phenoxybenzamine; Rats; Rats, Inbred Strains; Tissue Preservation; Tissue Survival | 1976 |
Ischemic damage of the liver. Part II: In vivo investigation of the prevention of the ischemic lesion of the liver.
Topics: Adenosine Triphosphate; Allopurinol; Animals; Aspartic Acid; Chlorides; Glucagon; Ischemia; Liver; Liver Regeneration; Magnesium; Methylprednisolone; Phenoxybenzamine; Rats | 1979 |
Evaluation of cytoprotective drugs for liver preservation by pyridine nucleotide fluorometry.
Topics: Allopurinol; Animals; Cell Membrane; Chlorpromazine; Dibucaine; Epoprostenol; Liver; Male; Mitochondria, Liver; Organ Preservation; Oxidation-Reduction; Phenoxybenzamine; Prostaglandins, Synthetic; Pyrimidine Nucleotides; Rats; Rats, Inbred Strains | 1988 |
Optimal management of warm ischemic kidneys prior to hypothermic preservation.
Topics: Allopurinol; Animals; Cadaver; Cold Temperature; Diuretics; Dogs; Humans; Ischemia; Kidney; Kidney Transplantation; Methylprednisolone; Organ Preservation; Perfusion; Phenoxybenzamine; Phentolamine; Tissue Preservation | 1974 |
Prevention of irreversible ischemic damage in renal preservation by pharmacological manipulation.
Topics: Allopurinol; Animals; Chlorpromazine; Dogs; Hypothermia; Ischemia; Kidney Transplantation; Methylprednisolone; Phenoxybenzamine; Tissue Preservation; Tissue Survival; Transplantation, Autologous | 1974 |